125 related articles for article (PubMed ID: 2376468)
21. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
[TBL] [Abstract][Full Text] [Related]
22. Quenched molecular dynamics simulations of tuftsin and proposed cyclic analogues.
O'Connor SD; Smith PE; al-Obeidi F; Pettitt BM
J Med Chem; 1992 Jul; 35(15):2870-81. PubMed ID: 1495018
[TBL] [Abstract][Full Text] [Related]
23. Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. A two-signal progenitor restricted, tuftsin-like effect.
Moore RN; Osmand AP; Dunn JA; Joshi JG; Rouse BT
J Immunol; 1988 Oct; 141(8):2699-703. PubMed ID: 2459223
[TBL] [Abstract][Full Text] [Related]
24. Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
Surkis R; Rubinraut S; Dagan S; Tzehoval E; Fridkin M; Ben Yoseph R; Catane R
Int J Biochem; 1990; 22(2):193-5. PubMed ID: 2332102
[TBL] [Abstract][Full Text] [Related]
25. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
[TBL] [Abstract][Full Text] [Related]
26. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity.
Gottlieb P; Tzehoval E; Feldman M; Segal S; Fridkin M
Biochem Biophys Res Commun; 1983 Aug; 115(1):193-200. PubMed ID: 6311202
[TBL] [Abstract][Full Text] [Related]
27. The evidence on the possible interleukin-1 alpha tuftsin competition.
Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and immunomodulatory activity of [60]fullerene-tuftsin conjugates.
Xu Y; Zhu J; Xiang K; Li Y; Sun R; Ma J; Sun H; Liu Y
Biomaterials; 2011 Dec; 32(36):9940-9. PubMed ID: 21937103
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and immunological evaluation of the conjugates composed from a muramyl peptide GMDP and tuftsin.
Titov VM; Meshcheryakova EA; Balashova TA; Andronova TM; Ivanov VT
Int J Pept Protein Res; 1995 Apr; 45(4):348-55. PubMed ID: 7601608
[TBL] [Abstract][Full Text] [Related]
30. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
Buchta R; Fridkin M; Pontet M; Romeo D
Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
[TBL] [Abstract][Full Text] [Related]
31. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity of [L-hydroxyproline]3-tuftsin analogue and its alpha- or beta-O-D-glucosylated derivatives.
Biondi L; Filira F; Rocchi R; Tzehoval E; Fridkin M
Int J Pept Protein Res; 1993 Jan; 41(1):43-51. PubMed ID: 8436445
[TBL] [Abstract][Full Text] [Related]
33. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
[TBL] [Abstract][Full Text] [Related]
34. Approaches to some biochemical mechanisms of action of tuftsin and analogues.
Kraus-Berthier L; Ferry G; Combe-Perez V; Visalli M; Remond G; Vincent M; Boutin JA
Biochem Pharmacol; 1991 May; 41(10):1411-8. PubMed ID: 1850275
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activity of tuftsin.
Martinez J; Winternitz F
Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
[TBL] [Abstract][Full Text] [Related]
36. Studies of human granulocyte phagocytosis stimulation by tuftsin.
Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
[TBL] [Abstract][Full Text] [Related]
37. Effect of intraperitoneal tuftsin administration on histamine concentration in tissues of guinea-pigs.
Paradowski A; Rózga M; Nawrocka E; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):153-7. PubMed ID: 1804046
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of a new carrier for immunization: polytuftsin. Two examples of its use with peptides selected in the hepatitis B surface antigen.
Trudelle Y; Brack A; Delmas A; Pedoussaut S; Rivaille P
Int J Pept Protein Res; 1987 Jul; 30(1):54-60. PubMed ID: 3667078
[TBL] [Abstract][Full Text] [Related]
39. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
[TBL] [Abstract][Full Text] [Related]
40. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
Fridkin M; Gottlieb P
Mol Cell Biochem; 1981 Dec; 41():73-97. PubMed ID: 7035869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
